Showing results (271-280 of 373) with videos related to
Sort By:
Pageof 38
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.Cell|May 20, 2026
Nociceptive innervation limits tertiary lymphoid structures to promote lung cancerYa-Hsuan Ho, Giacomo Bregni, Marco Stazi, et al.Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.Nature Communications|September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapyGuangchun Han, Guoliang Yang, Dapeng Hao, et al.Ebiomedicine|June 11, 2026
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergenceRuth Harvey, Ceilidh Welsh, Alexander Mp Byrne, et al.Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.Plos Biology|January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasionHarriet V Mears, George R Young, Theo Sanderson, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Extrachromosomal DNA driven oncogene spatial heterogeneity and evolution in glioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.Pageof 38